Literature DB >> 24182872

Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.

S Jarius1, B Wildemann.   

Abstract

BACKGROUND: Neuromyelitis optica (NMO, Devic's syndrome) is a severely disabling disorder of the central nervous system characterized by optic neuritis and longitudinally extensive myelitis. In around 80% of cases, NMO is caused by autoantibodies to astrocytic aquaporin-4 (AQP4), the most abundant water channel in the CNS. Acute NMO attacks are frequently accompanied by elevated levels of lactate in the cerebrospinal fluid (CSF). As a strongly dissociated anion (pK'=3.7) directly changing the strong ion difference, lactate causes a reduction in the dependent anion [HCO3-] and a rise in [H+], resulting in "metabolic" acidosis in the CSF. CSF acidosis also develops during respiratory failure due to brainstem or high cervical spinal cord lesions, the most common cause of death in NMO. However, lactic acid and more generally, a decrease in pH, has been shown to increase the membrane expression of AQP4 in astrocytes. An increase in AQP4 membrane expression during acute NMO attacks could potentially enhance the complement-mediated humoral immune reaction against AQP4-expressing astrocytes characteristic for NMO and, thus, result in more severe astrocytic damage. Moreover, lactate and acidosis have been shown to cause astrocytic swelling and to affect astrocytic viability, potentially rendering astrocytes more susceptible to AQP4-Ab-mediated damage. Finally, increased AQP4 expression could be an independent risk factor in NMO and other forms of CNS inflammation, as indicated by the finding of grossly attenuated experimental autoimmune encephalomyelitis in AQP4-null mice. Therefore, we hypothesize that CSF acidosis might play a role in the pathophysiology of AQP4-Ab-positive NMO and that alterations in CSF pH might possibly influence the outcome of acute attacks in this condition. In addition, we discuss potential clinical implications and make proposals on how to test the hypothesis. Finally, other factors that influence astrocytic AQP4 membrane expression and might play a role in NMO are discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AQP4; Ab; BBB; CNS; COX; CSF; EAE; IgG; NMO; SLE; antibodies; aquaporin-4; blood-brain barrier; central nervous system; cerebrospinal fluid; cyclooxygenase; experimental autoimmune encephalomyelitis; immunoglobulin G; neuromyelitis optica; systemic lupus erythematosus

Mesh:

Substances:

Year:  2013        PMID: 24182872     DOI: 10.1016/j.mehy.2013.10.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  11 in total

Review 1.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

2.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

Review 3.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  An association of Aquaporin-4 with the immunoregulation of liver pathology in mice infected with Schistosoma japonicum.

Authors:  Weiwei Zhang; Jifeng Zhu; Xian Song; Zhipeng Xu; Xue Xue; Xiaojun Chen; Xiaowei Yang; Yong Li; Xiaoxiao Dong; Sha Zhou; Wei Li; Yingying Qian; Feng Liu; Chuan Su
Journal:  Parasit Vectors       Date:  2015-01-21       Impact factor: 3.876

5.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Authors:  Sven Jarius; Ingo Kleiter; Klemens Ruprecht; Nasrin Asgari; Kalliopi Pitarokoili; Nadja Borisow; Martin W Hümmert; Corinna Trebst; Florence Pache; Alexander Winkelmann; Lena-Alexandra Beume; Marius Ringelstein; Oliver Stich; Orhan Aktas; Mirjam Korporal-Kuhnke; Alexander Schwarz; Carsten Lukas; Jürgen Haas; Kai Fechner; Mathias Buttmann; Judith Bellmann-Strobl; Hanna Zimmermann; Alexander U Brandt; Diego Franciotta; Kathrin Schanda; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-11-01       Impact factor: 8.322

6.  Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNS.

Authors:  Soo Jin Park; In Hye Jeong; Byung Soo Kong; Jung-Eun Lee; Kyoung Heon Kim; Do Yup Lee; Ho Jin Kim
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

7.  Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance.

Authors:  Hyun-Hwi Kim; In Hye Jeong; Ja-Shil Hyun; Byung Soo Kong; Ho Jin Kim; Sung Jean Park
Journal:  PLoS One       Date:  2017-07-26       Impact factor: 3.240

8.  Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.

Authors:  Sven Jarius; Hannah Pellkofer; Nadja Siebert; Mirjam Korporal-Kuhnke; Martin W Hümmert; Marius Ringelstein; Paulus S Rommer; Ilya Ayzenberg; Klemens Ruprecht; Luisa Klotz; Nasrin Asgari; Tobias Zrzavy; Romana Höftberger; Rafik Tobia; Mathias Buttmann; Kai Fechner; Kathrin Schanda; Martin Weber; Susanna Asseyer; Jürgen Haas; Christian Lechner; Ingo Kleiter; Orhan Aktas; Corinna Trebst; Kevin Rostasy; Markus Reindl; Tania Kümpfel; Friedemann Paul; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2020-09-03       Impact factor: 8.322

9.  S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version).

Authors:  H Tumani; H F Petereit; A Gerritzen; C C Gross; A Huss; S Isenmann; S Jesse; M Khalil; P Lewczuk; J Lewerenz; F Leypoldt; N Melzer; S G Meuth; M Otto; K Ruprecht; E Sindern; A Spreer; M Stangel; H Strik; M Uhr; J Vogelgsang; K-P Wandinger; T Weber; M Wick; B Wildemann; J Wiltfang; D Woitalla; I Zerr; T Zimmermann
Journal:  Neurol Res Pract       Date:  2020-03-16

Review 10.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.